Cargando…

METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression

BACKGROUND: N6-methyladenosine (m6A) RNA methylation and its methyltransferase METTL3 have been widely reported to be involved in different cancers by regulating RNA metabolism and function. Here, we aimed to explore the biological function and clinical significance of m6A modification and METTL3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu-qing, Wang, Qiang, Wang, Jun-guo, Gu, Ya-jun, Song, Pan-pan, Wang, Shou-yu, Qian, Xiao-yun, Gao, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919647/ https://www.ncbi.nlm.nih.gov/pubmed/35287752 http://dx.doi.org/10.1186/s40164-022-00256-3

Ejemplares similares

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
por: Wang, Zhihui, et al.
Publicado: (2010)

Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma
por: Xu, Pan, et al.
Publicado: (2021)

Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
por: Chen, Jie, et al.
Publicado: (2022)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Huo, Xing-xing, et al.
Publicado: (2021)

Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes
por: Maiti, Guru Prasad, et al.
Publicado: (2013)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
por: Nishioka, K, et al.
Publicado: (2001)

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
por: Han, Zewen, et al.
Publicado: (2019)

Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma
por: Guo, Chen, et al.
Publicado: (2019)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma
por: Wang, Hao-Fan, et al.
Publicado: (2022)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
por: Dong, Jun, et al.
Publicado: (2010)

MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023)

A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)

Alterations of GPI transamidase subunits in head and neck squamous carcinoma
por: Jiang, Wei-Wen, et al.
Publicado: (2007)

N (6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis
por: Guo, Ya, et al.
Publicado: (2021)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

The relevance between the immune response-related gene module and clinical traits in head and neck squamous cell carcinoma
por: Song, Yidan, et al.
Publicado: (2019)

FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma
por: Li, Xiaoxu, et al.
Publicado: (2023)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

METTL3 promotes cell cycle progression via m(6)A/YTHDF1-dependent regulation of CDC25B translation
por: Li, Huifeng, et al.
Publicado: (2022)

METTL3-dependent m(6)A modification programs T follicular helper cell differentiation
por: Yao, Yingpeng, et al.
Publicado: (2021)

Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma
por: Okuyama, Kohei, et al.
Publicado: (2023)

The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Expression of cdc25A and cdc25B proteins in thyroid neoplasms
por: Ito, Y, et al.
Publicado: (2002)

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma
por: Guan, Guo-fang, et al.
Publicado: (2016)

The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019)

METTL3 suppresses anlotinib sensitivity by regulating m(6)A modification of FGFR3 in oral squamous cell carcinoma
por: Chen, Jie, et al.
Publicado: (2022)

Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Jaime-Ramirez, Alena C., et al.
Publicado: (2017)

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
por: Miao, Xiangwan, et al.
Publicado: (2022)

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
por: Xu, Qiang, et al.
Publicado: (2020)

An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma
por: Bai, Guo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q28eposoektafinp24er23qfdj